12:00 AM
Sep 29, 2004
 |  BC Extra  |  Clinical News

Enzo Phase II Crohn's data

ENZ said its Alequel met the endpoints of clinical response and clinical remission in a Phase II trial in Crohn's disease. In the double-blind trial, data from 26 evaluable patients...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >